Pathological and therapeutic aspects of matrix metalloproteinases: implications in childhood leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathological and therapeutic aspects of matrix metalloproteinases: implications in childhood leukemia
Authors
Keywords
-
Journal
CANCER AND METASTASIS REVIEWS
Volume 38, Issue 4, Pages 829-837
Publisher
Springer Science and Business Media LLC
Online
2019-12-05
DOI
10.1007/s10555-019-09828-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL-60 cancer cell xenograft growth in vivo
- (2019) Yin-Chen Hsiao et al. ENVIRONMENTAL TOXICOLOGY
- The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia
- (2019) Yingjie Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Association of Matrix Metallopeptidase-2 Promoter Polymorphisms With the Risk of Childhood Leukemia
- (2019) PEI-CHEN HSU et al. ANTICANCER RESEARCH
- MicroRNA‑144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p‑ERK/c‑Myc/MMP‑2 pathway
- (2019) Ling Jiang et al. Oncology Letters
- Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells
- (2018) Ju-Fang Liu et al. BIOCHEMICAL PHARMACOLOGY
- Cantharidic acid induces apoptosis of human leukemic HL-60 cells via c-Jun N-terminal kinase-regulated caspase-8/-9/-3 activation pathway
- (2018) Shih-Chung Wang et al. ENVIRONMENTAL TOXICOLOGY
- Expression and clinical significance of serum MMP‑7 and PTEN levels in patients with acute myeloid leukemia
- (2018) Jiang Wu et al. Oncology Letters
- Glucose suppresses IL-1β-induced MMP-1 expression through the FAK, MEK, ERK, and AP-1 signaling pathways
- (2018) Tsung-Ju Wu et al. ENVIRONMENTAL TOXICOLOGY
- Expression and Activity of Matrix Metalloproteinases in Leukemia
- (2018) Ali Amin Asnafi et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line
- (2017) Avinaba Mukherjee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
- (2017) Yue Zhong et al. Expert Opinion on Drug Discovery
- Tricetin Induces Apoptosis of Human Leukemic HL-60 Cells through a Reactive Oxygen Species-Mediated c-Jun N-Terminal Kinase Activation Pathway
- (2017) Ming-Hsien Chien et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia
- (2017) Milena Gusella et al. TUMOR BIOLOGY
- Matrix Metalloproteinase-1 Genotype Contributes to the Risk of Non-solid Tumor in Childhood Leukemia
- (2016) JEN-SHENG PEI et al. ANTICANCER RESEARCH
- Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment
- (2016) Jia-Sin Yang et al. Expert Opinion on Drug Metabolism & Toxicology
- Melatonin suppresses TPA-induced metastasis by downregulating matrix metalloproteinase-9 expression through JNK/SP-1 signaling in nasopharyngeal carcinoma
- (2016) Hsin-Yu Ho et al. JOURNAL OF PINEAL RESEARCH
- Cancer metastasis: Mechanisms of inhibition by melatonin
- (2016) Shih-Chi Su et al. JOURNAL OF PINEAL RESEARCH
- Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group
- (2016) Uma H. Athale et al. PEDIATRIC BLOOD & CANCER
- Childhood Leukemia: A Preventable Disease
- (2016) C. Metayer et al. PEDIATRICS
- Childhood Leukemia and Primary Prevention
- (2016) Todd P. Whitehead et al. Current Problems in Pediatric and Adolescent Health Care
- NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells
- (2015) Ying-Jung Chen et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Global characteristics of childhood acute promyelocytic leukemia
- (2015) L. Zhang et al. BLOOD REVIEWS
- Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia
- (2015) Julie A. E. Irving BRITISH JOURNAL OF HAEMATOLOGY
- Moving targets: Emerging roles for MMPs in cancer progression and metastasis
- (2015) Gemma Shay et al. MATRIX BIOLOGY
- Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase
- (2015) CHUNHUAI WANG et al. Molecular Medicine Reports
- Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients
- (2014) A Wesołowska-Andersen et al. LEUKEMIA
- Glabridin Mediate Caspases Activation and Induces Apoptosis through JNK1/2 and p38 MAPK Pathway in Human Promyelocytic Leukemia Cells
- (2014) Hsin-Lien Huang et al. PLoS One
- Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide
- (2014) Irene Amigo-Jiménez et al. PLoS One
- Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells
- (2013) Wen-Hsin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
- (2013) Ajay Vora et al. LANCET ONCOLOGY
- Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview
- (2013) Ajay Kumar Chaudhary et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Matrix metalloproteinase-2 as a target for head and neck cancer therapy
- (2012) Ming-Hsien Chien et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl
- (2012) Ying-Jung Chen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
- (2012) Leah A. Marquez-Curtis et al. Cancers
- The Crosstalk Between the Matrix Metalloprotease System and the Chemokine Network in Acute Myeloid Leukemia
- (2011) K. J. Hatfield et al. CURRENT MEDICINAL CHEMISTRY
- Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians
- (2011) Judith Frances Margolin EUROPEAN JOURNAL OF PEDIATRICS
- Matrix Metalloproteinase-2 and -9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction Proteins
- (2011) Saran Feng et al. PLoS One
- Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
- (2010) Javier Redondo-Muñoz et al. CANCER CELL
- Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion
- (2010) Hiroshi Sato et al. CANCER SCIENCE
- Epidemiology of childhood cancer
- (2010) Peter Kaatsch CANCER TREATMENT REVIEWS
- Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway
- (2010) Wen-Hsin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation
- (2009) Håkon Reikvam et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2
- (2009) Ju Han Song et al. INTERNATIONAL JOURNAL OF CANCER
- mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor
- (2009) Carlos Alberto Scrideli et al. LEUKEMIA RESEARCH
- In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia
- (2009) Pascale Schneider et al. LEUKEMIA RESEARCH
- Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes
- (2008) Erica Travaglino et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started